ConditionRadiation-Induced Intestinal Injury
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorGeneral Hospital of Shenyang Military Region
About this trial
Due to the increasing number and prolonged survival of malignant tumor patients treated with radiotherapy, the complication, such as acute radiation-induced intestinal injury, has become increasingly significant. Glucocorticoids may play a therapeutic role by regulating the inflammatory response in patients with acute radiation-induced intestinal injury. However, the conclusions of related studies were controversial.
Eligibility criteria
Qualifiers
Grade II-III acute radiation-induced rectosigmoid injury
Signed informed consents
Age ≥18 years
Rstimated survival time >1 year
Disqualifiers
Absolute contraindications to glucocorticoids
A history of glucocorticoids treatment within 3 months
Inflammatory bowel disease or infectious intestinal disease
Recurrence of malignant tumor
Trial design
Treatments tested in this trial
- Dexamethasone
- Antibiotics, probiotics, vitamins, antidiarrheal drugs, enteral nutrition, and endoscopic argon plasma coagulation
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov